Volume 108, Issue 4 pp. 834-837

Haemophagocytic lymphohistiocytosis in X-linked severe combined immunodeficiency

E. Grunebaum

E. Grunebaum

Division of Immunology/Allergy, Department of Paediatrics, The Infection, Immunity, Injury and Repair Program, Research Institute, The Hospital for Sick Children and The University of Toronto, Canada

Search for more papers by this author
J. Zhang

J. Zhang

Division of Immunology/Allergy, Department of Paediatrics, The Infection, Immunity, Injury and Repair Program, Research Institute, The Hospital for Sick Children and The University of Toronto, Canada

Search for more papers by this author
H. Dadi

H. Dadi

Division of Immunology/Allergy, Department of Paediatrics, The Infection, Immunity, Injury and Repair Program, Research Institute, The Hospital for Sick Children and The University of Toronto, Canada

Search for more papers by this author
C. M. Roifman

C. M. Roifman

Division of Immunology/Allergy, Department of Paediatrics, The Infection, Immunity, Injury and Repair Program, Research Institute, The Hospital for Sick Children and The University of Toronto, Canada

Search for more papers by this author
First published: 24 December 2001
Citations: 27
Dr ChaimRoifman Infection, Immunity, Injury and Repair Program, Research Institute, The Hospital for Sick Children, 555 University Avenue, Toronto, ON M5G 1X8, Canada. e-mail: [email protected]

Abstract

Haemophagocytic lymphohistiocytosis (HLH) is characterized by destruction of haematopoietic elements, and is associated with a variety of manifestations including immune abnormalities. We describe an infant with HLH who had no evidence of infection or malignancy. He had markedly reduced natural killer (NK) and T-cell numbers and mitogen responses, consistent with severe combined immune deficiency. Western blot and flow cytometry analyses revealed an absence of interleukin (IL)-2 receptor γ (γ common) chain expression and a transition (C → T) at nucleotide 684 in the γ common gene. This novel case highlights the need for a thorough evaluation of immunological phenotype and genotype in patients with HLH.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.